FRET

By Ben Butkus
Biosearch Technologies said today that it has acquired worldwide rights from the University of Medicine and Dentistry of New Jersey to patents covering "non-FRET" nucleic acid probe technology.

The new test will be based on real-time PCR using fluorescence resonance energy transfer probes for detection.

The scientist has founded consulting firm Perpetual Genomics to license the technology, which would be a "true universal library" of extremely short FRET-based PCR probes that could allow manufacturers to sell probes fractionally and significantly reduce their cost.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.